世界の遺伝性血管性浮腫治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hereditary Angioedema Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5779 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、遺伝性血管性浮腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈、皮下、経口）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・遺伝性血管性浮腫治療薬の市場動向 ・企業の競争状況、市場シェア ・遺伝性血管性浮腫治療薬の種類別市場規模と予測2016-2027（静脈、皮下、経口） ・遺伝性血管性浮腫治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・遺伝性血管性浮腫治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・遺伝性血管性浮腫治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・遺伝性血管性浮腫治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遺伝性血管性浮腫治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・遺伝性血管性浮腫治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（BioCryst Pharma、Ionis Pharma、Pharming Group、CSL Limited、Shire、Attune Pharma、Adverum Biotechnologies、KalVista Pharma） ・結論

Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.

Market Analysis and Insights: Global Hereditary Angioedema Therapeutic Market
The global Hereditary Angioedema Therapeutic market size is projected to reach US$ 3050.6 million by 2027, from US$ 2088.6 million in 2020, at a CAGR of 5.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hereditary Angioedema Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hereditary Angioedema Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hereditary Angioedema Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hereditary Angioedema Therapeutic market.

Global Hereditary Angioedema Therapeutic Scope and Market Size
Hereditary Angioedema Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intravenous
Subcutaneous
Oral

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous
1.2.3 Subcutaneous
1.2.4 Oral
1.3 Market by Application
1.3.1 Global Hereditary Angioedema Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hereditary Angioedema Therapeutic Market Perspective (2016-2027)
2.2 Hereditary Angioedema Therapeutic Growth Trends by Regions
2.2.1 Hereditary Angioedema Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hereditary Angioedema Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Hereditary Angioedema Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Hereditary Angioedema Therapeutic Industry Dynamic
2.3.1 Hereditary Angioedema Therapeutic Market Trends
2.3.2 Hereditary Angioedema Therapeutic Market Drivers
2.3.3 Hereditary Angioedema Therapeutic Market Challenges
2.3.4 Hereditary Angioedema Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue
3.1.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hereditary Angioedema Therapeutic Revenue
3.4 Global Hereditary Angioedema Therapeutic Market Concentration Ratio
3.4.1 Global Hereditary Angioedema Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Angioedema Therapeutic Revenue in 2020
3.5 Hereditary Angioedema Therapeutic Key Players Head office and Area Served
3.6 Key Players Hereditary Angioedema Therapeutic Product Solution and Service
3.7 Date of Enter into Hereditary Angioedema Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hereditary Angioedema Therapeutic Breakdown Data by Type
4.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2022-2027)

5 Hereditary Angioedema Therapeutic Breakdown Data by Application
5.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hereditary Angioedema Therapeutic Market Size (2016-2027)
6.2 North America Hereditary Angioedema Therapeutic Market Size by Type
6.2.1 North America Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
6.3 North America Hereditary Angioedema Therapeutic Market Size by Application
6.3.1 North America Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
6.4 North America Hereditary Angioedema Therapeutic Market Size by Country
6.4.1 North America Hereditary Angioedema Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Hereditary Angioedema Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hereditary Angioedema Therapeutic Market Size (2016-2027)
7.2 Europe Hereditary Angioedema Therapeutic Market Size by Type
7.2.1 Europe Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
7.3 Europe Hereditary Angioedema Therapeutic Market Size by Application
7.3.1 Europe Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
7.4 Europe Hereditary Angioedema Therapeutic Market Size by Country
7.4.1 Europe Hereditary Angioedema Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Hereditary Angioedema Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type
8.2.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application
8.3.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region
8.4.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hereditary Angioedema Therapeutic Market Size (2016-2027)
9.2 Latin America Hereditary Angioedema Therapeutic Market Size by Type
9.2.1 Latin America Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Hereditary Angioedema Therapeutic Market Size by Application
9.3.1 Latin America Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Hereditary Angioedema Therapeutic Market Size by Country
9.4.1 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type
10.2.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application
10.3.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country
10.4.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BioCryst Pharma
11.1.1 BioCryst Pharma Company Details
11.1.2 BioCryst Pharma Business Overview
11.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Introduction
11.1.4 BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
11.1.5 BioCryst Pharma Recent Development
11.2 Ionis Pharma
11.2.1 Ionis Pharma Company Details
11.2.2 Ionis Pharma Business Overview
11.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Introduction
11.2.4 Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
11.2.5 Ionis Pharma Recent Development
11.3 Pharming Group
11.3.1 Pharming Group Company Details
11.3.2 Pharming Group Business Overview
11.3.3 Pharming Group Hereditary Angioedema Therapeutic Introduction
11.3.4 Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
11.3.5 Pharming Group Recent Development
11.4 CSL Limited
11.4.1 CSL Limited Company Details
11.4.2 CSL Limited Business Overview
11.4.3 CSL Limited Hereditary Angioedema Therapeutic Introduction
11.4.4 CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
11.4.5 CSL Limited Recent Development
11.5 Shire
11.5.1 Shire Company Details
11.5.2 Shire Business Overview
11.5.3 Shire Hereditary Angioedema Therapeutic Introduction
11.5.4 Shire Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
11.5.5 Shire Recent Development
11.6 Attune Pharma
11.6.1 Attune Pharma Company Details
11.6.2 Attune Pharma Business Overview
11.6.3 Attune Pharma Hereditary Angioedema Therapeutic Introduction
11.6.4 Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
11.6.5 Attune Pharma Recent Development
11.7 Adverum Biotechnologies
11.7.1 Adverum Biotechnologies Company Details
11.7.2 Adverum Biotechnologies Business Overview
11.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Introduction
11.7.4 Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
11.7.5 Adverum Biotechnologies Recent Development
11.8 KalVista Pharma
11.8.1 KalVista Pharma Company Details
11.8.2 KalVista Pharma Business Overview
11.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Introduction
11.8.4 KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
11.8.5 KalVista Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous
Table 3. Key Players of Subcutaneous
Table 4. Key Players of Oral
Table 5. Global Hereditary Angioedema Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hereditary Angioedema Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hereditary Angioedema Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hereditary Angioedema Therapeutic Market Share by Regions (2016-2021)
Table 9. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hereditary Angioedema Therapeutic Market Share by Regions (2022-2027)
Table 11. Hereditary Angioedema Therapeutic Market Trends
Table 12. Hereditary Angioedema Therapeutic Market Drivers
Table 13. Hereditary Angioedema Therapeutic Market Challenges
Table 14. Hereditary Angioedema Therapeutic Market Restraints
Table 15. Global Hereditary Angioedema Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hereditary Angioedema Therapeutic Market Share by Players (2016-2021)
Table 17. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Therapeutic as of 2020)
Table 18. Ranking of Global Top Hereditary Angioedema Therapeutic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hereditary Angioedema Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hereditary Angioedema Therapeutic Product Solution and Service
Table 22. Date of Enter into Hereditary Angioedema Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2016-2021)
Table 26. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hereditary Angioedema Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2016-2021)
Table 30. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hereditary Angioedema Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hereditary Angioedema Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hereditary Angioedema Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hereditary Angioedema Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 62. BioCryst Pharma Company Details
Table 63. BioCryst Pharma Business Overview
Table 64. BioCryst Pharma Hereditary Angioedema Therapeutic Product
Table 65. BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
Table 66. BioCryst Pharma Recent Development
Table 67. Ionis Pharma Company Details
Table 68. Ionis Pharma Business Overview
Table 69. Ionis Pharma Hereditary Angioedema Therapeutic Product
Table 70. Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
Table 71. Ionis Pharma Recent Development
Table 72. Pharming Group Company Details
Table 73. Pharming Group Business Overview
Table 74. Pharming Group Hereditary Angioedema Therapeutic Product
Table 75. Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
Table 76. Pharming Group Recent Development
Table 77. CSL Limited Company Details
Table 78. CSL Limited Business Overview
Table 79. CSL Limited Hereditary Angioedema Therapeutic Product
Table 80. CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
Table 81. CSL Limited Recent Development
Table 82. Shire Company Details
Table 83. Shire Business Overview
Table 84. Shire Hereditary Angioedema Therapeutic Product
Table 85. Shire Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
Table 86. Shire Recent Development
Table 87. Attune Pharma Company Details
Table 88. Attune Pharma Business Overview
Table 89. Attune Pharma Hereditary Angioedema Therapeutic Product
Table 90. Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
Table 91. Attune Pharma Recent Development
Table 92. Adverum Biotechnologies Company Details
Table 93. Adverum Biotechnologies Business Overview
Table 94. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product
Table 95. Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
Table 96. Adverum Biotechnologies Recent Development
Table 97. KalVista Pharma Company Details
Table 98. KalVista Pharma Business Overview
Table 99. KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
Table 100. KalVista Pharma Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Angioedema Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Features
Figure 3. Subcutaneous Features
Figure 4. Oral Features
Figure 5. Global Hereditary Angioedema Therapeutic Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Hereditary Angioedema Therapeutic Report Years Considered
Figure 10. Global Hereditary Angioedema Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hereditary Angioedema Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hereditary Angioedema Therapeutic Market Share by Regions: 2020 VS 2027
Figure 13. Global Hereditary Angioedema Therapeutic Market Share by Regions (2022-2027)
Figure 14. Global Hereditary Angioedema Therapeutic Market Share by Players in 2020
Figure 15. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Therapeutic as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hereditary Angioedema Therapeutic Revenue in 2020
Figure 17. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2016-2021)
Figure 18. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2022-2027)
Figure 19. North America Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
Figure 21. North America Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
Figure 22. North America Hereditary Angioedema Therapeutic Market Share by Country (2016-2027)
Figure 23. United States Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
Figure 27. Europe Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
Figure 28. Europe Hereditary Angioedema Therapeutic Market Share by Country (2016-2027)
Figure 29. Germany Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Region (2016-2027)
Figure 39. China Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
Figure 47. Latin America Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
Figure 48. Latin America Hereditary Angioedema Therapeutic Market Share by Country (2016-2027)
Figure 49. Mexico Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Country (2016-2027)
Figure 55. Turkey Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. BioCryst Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
Figure 59. Ionis Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
Figure 60. Pharming Group Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
Figure 61. CSL Limited Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
Figure 62. Shire Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
Figure 63. Attune Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
Figure 64. Adverum Biotechnologies Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
Figure 65. KalVista Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---